WALTHAM, MA—August 10, 2021 — CorEvitas, LLC, the leading sponsor of registries in autoimmune and inflammatory diseases announces first patient enrollment in a new biospecimen study for patients enrolled in its rheumatology registries. Eligible rheumatology registry patients...Learn More
News
Aug 10 2021 - 7:00am
News
Sep 21 2021 - 7:00am
Insights advance clinical development, inform trial design and recruitment, substantiate value narratives, and inform patient-specific intervention plans
Waltham, MA, September 21, 2021—CorEvitas, LLC, the gold-standard leader in longitudinal real-world data in...Learn More
News
Aug 3 2021 - 7:00am
Waltham, MA and London, UK, August 3, 2021—CorEvitas, LLC welcomes Amrit Ray, MD, MBA, to its Board of Directors. CorEvitas [kohr-eh'-vi-tahs] is the built-for-purpose provider of gold-standard real-world evidence, striving to advance patient care by generating high quality...Learn More
News
Jul 22 2021 - 6:00am
Retina specialty data provider combines with leader in real-world evidence
Waltham, MA, USA, London, UK, and Naperville, IL, USA, July 22, 2021—CorEvitas, LLC is pleased to share the addition of Vestrum Health to its organization.
Vestrum Health, the first-to-...Learn More